ArtsBoston is a nonprofit dedicated to supporting the arts.
Owned and developed by DivcoWest, a national operator, owner, and developer of real estate in innovation markets across the country, CX is a new neighborhood comprised of 43-acres at the intersection of Boston, Cambridge, and Somerville and is part of the Kendall Square community. As the new home to world-class life science companies Bristol Myers Squibb, Philips, Sanofi, and Cerevel Therapeutics, this innovation hub offers 11 acres of public green spaces including a central common, a picnic grove, a hardscape park with a water feature, and a dog park.
CX is easily accessible by two MBTA stations, including the Lechmere Green Line stop on site and the Community College Orange Line stop just a few minutes away, buses, cycling and walking paths, and ride and bike shares.
At completion, CX will be comprised of 4.5 million square feet of commercial, residential, and retail. Two million square feet of commercial space is currently under construction, and preleasing for Park 151, a 20-story 468-unit multifamily building, has commenced.